Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 2376 - 2400 of 3051 in total
Investigational
Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2). This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.
Investigational
Modified vaccinia virus Ankara-85A antigen is under investigation in clinical trial NCT00953927 (A Study of MVA85A in Healthy Infants).
Investigational
Matched Categories: … Recombinant Proteins …
UC-781 is a thiocarboxanilide non-nucleoside reverse transcriptase inhibitor (NNRTI). It is a topical microbicide targeted against the AIDS virus.
Investigational
Experimental
Investigational
Inarigivir is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)).
Investigational
Matched Description: … Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12
TRC093 is a recombinant humanized IgG1k monoclonal antibody.
Investigational
Matched Description: … TRC093 is a recombinant humanized IgG1k monoclonal antibody. …
Lusacomfar Alfa is a recombinant complement factor H
Investigational
Matched Description: … Lusacomfar Alfa is a recombinant complement factor H …
Rivanicline (TC-2403, RJR-2403, (E)-metanicotine) is a partial agonist at neuronal nicotinic acetylcholine receptors, binding primarily to the α4β2 subtype. It was originally developed as a potential treatment for Alzheimer's disease for its nootropic effects but has also been found to inhibit the production of Interleukin-8. It has subsequently been developed...
Investigational
Matched Description: … Alzheimer's disease for its nootropic effects but has also been found to inhibit the production of Interleukin
MB-102 are autologous T cells genetically modified to express CD123-specific, hinge-optimized CD28-costimulatory chimeric receptor and a truncated human epidermal growth factor receptor.
Investigational
Matched Description: … modified to express CD123-specific, hinge-optimized CD28-costimulatory chimeric receptor and a truncated human
The glycine conjugate of cholic acid. It acts as a detergent to solubilize fats for absorption and is itself absorbed.
Experimental
Investigational
M-701 is a recombinant anti-EpCAM/CD3 bispecific antibody.
Investigational
Matched Description: … M-701 is a recombinant anti-EpCAM/CD3 bispecific antibody. …
Leridistim is under investigation in clinical trial NCT00004215 (Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia).
Investigational
Matched Categories: … Recombinant Proteins …
mRNA-1345 is an investigational RSV vaccine.
Investigational
Matched Categories: … Recombinant Proteins …
Investigational
7-ethyl-10-hydroxycamptothecin (SN 38) is a liposomal formulation of the active metabolite of Irinotecan DB00762, a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer. SN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative...
Investigational
Aramchol has been used in trials studying the treatment of HIV, Gallstones, Fatty Liver, Metabolic Syndrome, and Nonalcoholic Steatohepatitis, among others.
Investigational
Investigational
Matched Categories: … Recombinant Proteins …
Inarigivir soproxil is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)).
Investigational
Matched Description: … Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12
RO7200220 is a recombinant fully humanized anti-IL 6 monoclonal antibody.
Investigational
Matched Description: … RO7200220 is a recombinant fully humanized anti-IL 6 monoclonal antibody. …
M1-c6v1 is a recombinant oncolytic virus.
Investigational
Matched Description: … M1-c6v1 is a recombinant oncolytic virus. …
Pidacmeran is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).
Investigational
Matched Categories: … Recombinant Proteins …
Displaying drugs 2376 - 2400 of 3051 in total